BioSpace News Archive

Puma Biotechnology, Inc., a biopharmaceutical company, announced that on September 2, 2020 the Compensation Committee of Puma’s Board of Directors approved the grant of inducement restricted stock unit awards covering an aggregate of 66,688 shares of Puma common stock to 10 new non-executive employees.

All pharmacists should be in the first tier of providers for receiving the COVID-19 vaccine to ensure that pharmacists are able to continue providing critical care to their patients, said Scott J. Knoer, MS, PharmD, FASHP, in testimony this week to a committee of the National Academies of Science, Engineering and Medicine.

Crinetics Pharmaceuticals, announced that management will participate in the following conferences in the month of September and invites investors to participate by webcast. Please see additional details below

InxMed Co., Ltd., a clinical stage biotech company dedicated to developing innovative, individualized medicines with international impact, announced the completion of its Series A+ financing of 130M RMB.

BioAegis Therapeutics Inc. announces publication of “Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant Pseudomonas aeruginosa Pneumonia.” Recombinant human plasma gelsolin is currently being studied in severe COVID-19 patients where lung injury is a key hallmark of severe disease.